Saturday, July 21, 2018
Company News: Page (1) of 1 - 04/12/18 Email this story to a friend. email article Print this page (Article printing at page facebook
Pharmacogenomics Market 2018 Statistics | By Technology - Microarray, Sequencing, Polymerase Chain Reaction | Ravishing Growth of 5.8% by 2023

(April 12, 2018)

"Pharmacogenomics Market"
Pharmacogenomics Market Research Report, By Application (Cardiology, Neurological Disorders) By End Users (Hospitals, Research Organizations, Academic Institute) - Global Forecast till 2023

The Global Pharmacogenomics Market is expected to grow at a ~CAGR of 5.8% during the forecast period.

Competitive Analysis

The key players profiled in pharmacogenomics market report includes Myriad

  • Genetics Inc. (U.S.),
  • 23andMe Inc. (U.S.),
  • Pathway Genomics (U.S.),
  • GeneTech (U.S.),
  • GeneDx (U.S.),
  • Future Science Group (U.S.),
  • Teva Pharmaceutical Industries Ltd. (Israel),
  • Assurex Health Inc. (U.S.),
  • OneOme (U.S.)

Market Overview:

Pharmacogenomics characterizes how qualities can influence a man's reaction to drugs. It is moderately another field and joins pharmacology and genomics. The point of pharmacogenomics is to create compelling and safe medicines. Additionally by pharmacogenomics, drugs measurements can be custom-made to a man's hereditary cosmetics. The field of pharmacogenomics is anticipated to treat an extensive variety of medical issues including cardiovascular infections, Alzheimer illness, growth, HIV/AIDS, and asthma, in not so distant future.

Get a Sample Copy of This Report @ .

As per the Organization for Economic Co-activity and Development (2017), biotech R&D in the business venture division was 11.3%, and 9.4% for U.S. furthermore, France separately in 2014. Besides, in 2016, as indicated by the organization BIOCOM AG, the aggregate turnover for the Germany based biotech organizations was USD 3.7 billion. The above information reasons that the biotechnology business is extending. This developing biotech segment alongside the rising human services uses, and expanding enthusiasm for modified medications will drive the market development. In any case, absence of mindfulness and absence of consistency in pharmacogenomics items will control the market development amid the conjecture time frame.

Regional Analysis:

The Americas dominate the global pharmacogenomics market owing to a well-developed healthcare sector and presence of developed economies like the U.S. and Canada. Moreover, increasing number of patients suffering from cardiovascular diseases and rising healthcare expenditure have boosted the growth of the market in America. In 2016, according to the Centres for Diseases Control and Prevention in the U.S., heart disease was the leading cause of death for both men and women. Moreover, it was also estimated that the healthcare expenditure for heart diseases in the U.S. reaches USD 200 billion each year.

Europe is the second largest pharmacogenomics market, followed by Asia Pacific. Availability of funds for research and development along with government support and presence of huge patient population within the region will drive the market growth during the forecast period. Moreover, the presence of the developed economies like Germany and France within the region fuels the market growth.

Get Attractive Discount on This Report @ .

Asia Pacific is the fastest growing region for the market due to the presence of a huge patient population, continuously developing economies like India and China and presence of huge opportunities in the market drives the market. According to the Indian Brand Equity Foundation in 2016, the Indian biotech industry is estimated to reach USD 100 billion by 2025 from USD 7 billion in 2015 with a CAGR of 30.46%.

On the other hand, the Middle East & Africa has the least share in the global pharmacogenomics market due to presence of poor economy, low per capita healthcare expenditure and stringent government policies especially in the Africa region. The majority of the market of this region is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure. Moreover, developed economies like Dubai, Saudi Arabia, Dubai, besides others fuels the market growth within the Middle East & Africa region.

Intended Audience:

  • Pharmaceutical companies
  • Biotechnological institutes
  • Government and Private Laboratories
  • Research and Development (R&D) Companies
  • Medical Research Laboratories
  • Market Research and Consulting Service Providers


Inquire about This Report @ .

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Media Contact

Company Name: Market Research FutureContact Person: Akash Anand

Email: [email protected]
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune -
City: Pune
State: Maharashtra
Country: India


Page: 1

Related Keywords:Business,Health & Medicine,Pharmaceuticals & Biotech,U.S,World,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   IBN - IT Weekly Newsletter ,   DMN Newswire Newsletter

  • Healthcare IT Market 2018 - 2023 with SWOT Analysis regarding upcoming Changes and Technology Adaptations in Global Healthcare Sector
  • Vision Care Product Market To Witness Enhanced Growth Owing To Rising Occurrence Of Eye Disorders Till 2021 | Million Insights
  • Global Prosthetic Heart Valve Market Reaching at a CAGR of +12.70% by Geography, Deployment Model, Component, and Key players are Boston Scientific Cardiology, CryoLife, Inc., Abbott
  • Trauma Fixation Global Market to Register Steady Expansion During 2018-2025
  • Global Surgical Apparel Market Will Reach USD 2,966.58 million by 2024: Zion Market Research

  • Mesothelioma is a Deadly Cancer and it’s Completely Preventable
  • HedgePath Pharmaceuticals Granted Exclusive Option to License UCONN's Patented Chemical Analogues of Itraconazole
  • Alligator Bioscience Submits Application to Start Clinical Phase I Study in Cancer Patients with ATOR-1015, a Unique CTLA-4 and OX40 Binding Antibody
  • Yisheng Biopharma Announces Opening of New Business Divisions in Cambodia, Expanding Presence within Southeast Asia
  • Omega-3 Market to Reach US$ 16.37 Bn by 2023, Globally -

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines